Peter Popella
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The Polycyclic Polyprenylated Acylphloroglucinol Antibiotic PPAP 23 Targets the Membrane and Iron Metabolism in Staphylococcus aureus.
Journal: Frontiers in microbiology
Published: September 26, 2018
Lantibiotic production is a burden for the producing staphylococci.
Journal: Scientific reports
Published: December 18, 2017
Correction for Ebner et al., "Excreted Cytoplasmic Proteins Contribute to Pathogenicity in Staphylococcus aureus".
Journal: Infection and immunity
Published: November 19, 2017
Polycyclic Polyprenylated Acylphloroglucinols: An Emerging Class of Non-Peptide-Based MRSA- and VRE-Active Antibiotics.
Journal: Angewandte Chemie (International ed. in English)
Published: July 11, 2017
Non-classical Protein Excretion Is Boosted by PSMα-Induced Cell Leakage.
Journal: Cell reports
Published: April 07, 2017
Excreted Cytoplasmic Proteins Contribute to Pathogenicity in Staphylococcus aureus.
Journal: Infection and immunity
Published: February 13, 2016
VraH Is the Third Component of the Staphylococcus aureus VraDEH System Involved in Gallidermin and Daptomycin Resistance and Pathogenicity.
Journal: Antimicrobial agents and chemotherapy
Published: November 30, 2015
Excretion of cytoplasmic proteins (ECP) in Staphylococcus aureus.
Journal: Molecular microbiology
Published: May 19, 2015
Epidermin and gallidermin: Staphylococcal lantibiotics.
Journal: International journal of medical microbiology : IJMM
Published: October 15, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026